Michael Cooreman
Company: Inventiva Pharma
Job title: Chief Medical Officer
Seminars:
Panel Discussion: Reflecting on the Last 3 Years in NASH: Is there a Horizon Beyond the Setbacks? 11:30 am
What has worked and what hasn’t? Do we need a new normal in trial design and clinical development for NASH? Adapting mindsets: how do we ‘fail earlier’ to accelerate the pathway to successful therapies?Read more
day: Day 1 Stream 2 AM